SnagRx vs Embody GLP1: Same Owner, Two Different Prices

By the WPG Research Team · Weight Loss Provider Guide Last verified: August 12, 2026

Affiliate disclosure: Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We may earn a commission if you start with Embody or another linked provider, including Ro. We earn nothing from SnagRx — they don't have a program with us. You should know that before you read our verdict. That payment does not buy a better verdict. Everything below comes from documents you can open yourself, and we've linked all of them. If our verdict doesn't match the documents, the documents win.

Embody is the better buy in a SnagRx vs Embody GLP1 comparison — but not for the reason most sites give.

Both storefronts are run by the same company: Modern Metabolic Medicine, Inc. They name the same clinician network and the same four pharmacy partners. Their refund pages use the same core rules and sequence, but they are not word-for-word identical.

For a shopper who accepts that shared setup, the main buying difference is price. Month to month, Embody lists $79 for compounded semaglutide. SnagRx lists $99. If you stayed month to month for 12 months, the difference would be $240 for the same published care chain.

And if you saw Embody or SnagRx advertised at $69 a month, that rate belongs to the 12-month semaglutide plan — not month to month.

We read both companies' live terms, refund pages, homepages, and public product or landing pages on August 12, 2026. We also traced SnagRx's crossed-out "$299" to the "retail comparison price" written into its own terms.

The verdict, at a glance

Fastest way to see your own number: Jump to the real-cost calculator ↓

What is verified, what is only advertised

Are SnagRx and Embody the same company?

Yes. Both websites are operated by Modern Metabolic Medicine, Inc., a Delaware company at 1811 Silverside Road in Wilmington. Both companies state this in their own terms, and the Better Business Bureau keeps one business file that lists SnagRx, RodeoMeds, and Embody as alternate names of the same business.

You noticed something real. Two sites. Nearly the same layout. The same crossed-out prices. SnagRx's homepage and a live Embody landing page also showed the same wall of seven press logos — Forbes, Stanford Medicine, Healthline, Fortune, NBC, The New York Times, Bloomberg — in the same order, with no source article linked from the logo wall.

That wasn't your imagination. Here are the receipts.

The paperwork says it plainly

SnagRx's terms: "Modern Metabolic Medicine, Inc. owns and operates snagrx.com."

Embody's terms footer: "Modern Metabolic Medicine, Inc. is the legal entity operating Embody (joinem.co)."

The BBB: one file for the business. Under "Alternate Names" it lists SnagRx, RodeoMeds, and Embody. The "Visit Website" button on that file goes to joinem.co. snagrx.com is listed underneath as an additional website of the same business.

You can check all three in about four clicks. We'd rather you did.

What's shared, what's different

We lined the two up field by field from their own terms and pages. Take a minute with it.

About the ZIP: both companies' terms print 19180. The BBB lists the same street and suite as 19810. Do not silently replace the contract address with the BBB address. SnagRx's terms clearly allow an arbitration opt-out by email or mail. Embody lists a mailing address and support email under its opt-out instructions, but it does not clearly say email alone is enough. For Embody, send tracked mail to the address printed in the current terms, copy support by email, save both, and ask the company to confirm the ZIP in writing.

What shared ownership does not prove

This is the part other pages get wrong in the other direction. Same company does not mean same experience.

• It does not mean the same clinician reviews you.
• It does not mean the same pharmacy fills your order. Neither brand names your pharmacy before you pay.
• It does not mean the same vial, the same strength, or the same supplies.
• It does not mean support responds the same way.
• And it absolutely does not make a compounded drug FDA-approved.

Don't call the products identical. Your prescription label — not a website graphic — tells you what you actually got.

What real people are saying about this

We pulled these from Reddit threads to understand how people describe the problem, not as proof of anything medical or legal. One commenter pointed to the same LLC and said it "feels like a red flag." Another wrote: "Yikes… I didn't realize that was Embody's real name."

You were right to notice. That's the honest response. Sharing an owner is a real fact you deserve to know — it isn't proof that anyone did anything wrong.

Is Embody really different from SnagRx? The one thing we won't dress up

Embody does not give you a different parent company, a different clinician network, or a different listed pharmacy pool than SnagRx. If your goal is to get away from Modern Metabolic Medicine, Embody is not the escape hatch. Neither is switching from one to the other after a bad experience. Same file. Same F rating. Same 21 unanswered complaints. If your goal is a company outside Modern Metabolic Medicine and an FDA-approved medication, Ro is one path, and we'll show you that door later on this page.

But flip it over, because this cuts the other way too.

If the published care chain is the same at both — same operator, same clinician network, same listed pharmacy pool, and the same core subscription rules — then SnagRx's documents do not show what its extra $20 buys you. You're not choosing a different company by taking the lower price. If you stay month to month for 12 months, SnagRx costs $240 more for the same published core setup with a different logo on it.

That's the whole reason this comparison has an answer.

SnagRx vs Embody GLP1: which one is actually cheaper?

Embody is cheaper on the monthly, three-month, and six-month plans for both medications. The 12-month prices tie exactly. These figures come from each company's own published terms, read on August 12, 2026.

Here it is. Both ladders, side by side.

Compounded semaglutide

Compounded tirzepatide

How we got these numbers: SnagRx's terms publish both the per-month rate and the exact lump sum ("billed as $828 once"). Embody's terms publish the per-month rates, and its public catalog lists all six multi-month totals: $228, $438, and $828 for semaglutide; $378, $738, and $1,428 for tirzepatide. The savings column is our arithmetic. Embody still does not state the billing timing for every bundle in one clear place. Confirm the exact amount charged today in checkout.

Three findings buried in that table

1. The ladders meet at the top and nowhere else. Both charge exactly $69 and $119 on the 12-month plan. Below that, Embody is cheaper every single time. One company. Two price lists. They converge only when you commit for a year.

2. Month to month, the same company charges 25% more at one of its own storefronts. $99 versus $79. Nothing in either company's documents explains why.

3. One point goes to SnagRx — and we're going to give it to them. SnagRx tells you the lump sum and the timing. Its terms spell out billed as $267 once, $474 once, and $828 once. Embody's public catalog shows all six multi-month totals, but its terms say charges recur monthly or by the selected plan and do not cleanly state when every bundle total leaves your card. On billing timing, SnagRx's paperwork is clearer. A comparison where one side sweeps every category isn't a comparison. It's an ad.

The flat-price footnote both brands bury

Both sets of terms say the final charge may vary based on the prescribed medication and selected pharmacy, and that support will notify you if it changes. That sits in tension with the flat-price and no-surprise language in their ads. The listed rates are real published rates, but they are not a promise that no pharmacy- or prescription-based adjustment can happen. Save the checkout amount and any later price notice.

Your real cost, in four taps

Pick a brand, medication, plan length, and your next renewal or prescription-period end date. The calculator shows the published rate, full commitment total, price at the other brand, billing-timing warning, statement descriptor, and a five-day planning date.

No email required. It is arithmetic, not a quote. The checkout screen and prescription label are what count.

Decision point. You now know they're one company and you know which door is cheaper. If the shared setup doesn't bother you and you want the lower number, that's a reasonable call to make.

→ Check Embody's current price and see if you qualify

Prescription required. Compounded medication is not FDA-approved. Confirm your plan length and the amount charged today before you pay.

Should you pick monthly, 3 months, 6 months, or 12?

Monthly is the safer starting point if you've never used either company. It costs more per month, but you haven't yet tested their support, their shipping, or whether a clinician will even approve you. Longer plans lower the rate and put more money or time under one commitment.

Most sites push you toward the biggest bundle because the headline number looks best. We're going to argue against that, at least for your first month.

Start monthly if you're new here

Choose the month-to-month plan if any of these is true:

• You've never ordered from either brand.
• You don't know yet which pharmacy will fill your prescription.
• You're not sure a clinician will approve you.
• You want to see how fast support answers before you trust them with more.
• Losing access to prepaid money during a billing dispute would hurt.

Embody's monthly plan is $79 for semaglutide and $129 for tirzepatide. That's $20 less than SnagRx either way, and it puts the least money under one commitment while you test the service.

The 3-month plan: check the charge first

Embody's public catalog lists $228 for a three-month semaglutide supply. SnagRx says outright that it bills $267 at once.

Here's the trap: "three-month plan" does not automatically mean three monthly payments. SnagRx tells you it's one charge. Embody shows the $228 total but does not explain the billing timing cleanly across its terms and product pages. Before you click, find out whether $228 hits today or $76 is charged each month.

The 6-month plan: it's about trust, not $6

The savings over SnagRx across six months is $36 total. That's real, but it's not the decision. The decision is whether you're comfortable being responsible for a six-month commitment with a company that has 21 unanswered complaints on file. That's a personal call and we're not going to make it for you.

The 12-month plans are a tie — read this twice

At current published rates:

• Semaglutide: $828 either way.
• Tirzepatide: $1,428 either way.

Do not pick SnagRx's annual plan thinking it's the cheaper one. It isn't. If you're going to commit for a year, and SnagRx can't show you something Embody doesn't offer, there's no published reason to choose it.

One thing to ignore completely

SnagRx's homepage runs a countdown timer that reads "Price increases in 00:00:00:00" — sitting at zero. Next to it, the headline promises pricing "locked in for life." The "Summer Start" promotion was still live at our August 12 check even though the timer was at zero.

Don't let a timer set your deadline. Your real deadline is your own renewal date, and you'll find that in your account, not in an ad.

Decision point. You know the price and you know the term. If starting small feels right, start small.

→ See Embody's month-to-month plan and check availability in your state

The monthly rate is $79 for semaglutide. The $69 you may have seen is the 12-month plan.

Can you cancel SnagRx or Embody, and get money back?

You can stop future charges at either one, but that doesn't undo a multi-month commitment you already agreed to. Both companies publish two different cancellation deadlines that contradict each other — 72 hours in the refund page and 5 days in the terms. Use at least 5 days at both, use any longer cutoff shown at checkout, put it in writing, and get confirmation.

This is where people get hurt, so we're going to be specific.

The deadline conflict — identical at both brands

Neither company has fixed the gap between its own two documents. Use the 5-day rule. It's the stricter of the two, and it's the one in the terms you actually agree to.

The refund window nobody explains

Read these two sentences together and you'll see it.

Both refund policies say you can get a refund for your current cycle only if "your medication has not been ordered" — and that for new patients, ordering generally happens when you submit your intake form.

Both sets of terms say your initial charge happens at checkout.

Put those together. You may pay at checkout. Then you fill out the intake form. Under the refund pages, the medication-order point generally arrives when you submit that form, or when a required live visit ends.

In plain terms: the refund window may close as soon as you submit the intake or finish the visit. Neither company puts the charge timing and the medication-order cutoff into one clean sentence. So we did.

Both refund policies also say refunds only apply to your most recent billing cycle — never past ones.

What happens if a doctor says no

Both refund pages promise a full refund if a medical provider disqualifies you. But both sets of terms say medical consultation fees are not refundable and say an ineligible patient may receive a refund only for medication not yet dispensed.

So the honest answer is that their documents conflict. Do not assume the full checkout charge or only part of it will come back. Before you submit the intake, ask what exact dollar amount is refunded if the clinician says no, and save the answer.

The guarantee that isn't in the contract

Embody advertises a "100% satisfaction refund" if you follow the program and don't see "meaningful progress" in six months.

SnagRx says if you're unhappy, "we'll make it right." No timeframe. No amount.

Here's what we found: neither guarantee appears in either company's terms or refund policy. Embody even has a menu link labeled "100% REFUND POLICY" that leads to a refund page which never mentions the guarantee at all.

That doesn't mean it's fake. It means it isn't in the contract you're signing. Embody's version at least has a defined window, which is more than SnagRx's has. If you're counting on it, email support and get the written terms before you pay — the eligibility rules, the documentation, and the deadline to file.

Arbitration, in normal words

Both companies' terms say most disputes go to private arbitration instead of court, and both waive class actions. Both give you 30 days to opt out.

The forums are different — SnagRx uses JAMS, Embody uses AAA — and SnagRx adds a one-year deadline to bring a claim, which Embody's terms don't state.

This is a contract summary, not legal advice. The ZIP conflict matters here: the terms print 19180, while the BBB prints 19810. SnagRx clearly permits an opt-out by email or mail. Embody lists a mailing address and support email under its opt-out instructions, but it does not clearly say email alone is enough. For Embody, send tracked mail to the address printed in the current terms, copy support by email, save both, and ask the company to confirm the ZIP in writing.

Your five-step cancellation record

1. Screenshot your plan and your next renewal date on day one.
2. Cancel in the account and by email, at least 5 days out.
3. Send the email from the address on your account.
4. Save the sent email, the confirmation, and any ticket number.
5. Check your card statement after the renewal date to confirm it actually stopped.

Do SnagRx and Embody use the same doctors and pharmacies?

Both brands name OpenLoop Health as their clinician network and list the same four pharmacy partners: RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy, and Triad Rx. That means a shared network and a shared pharmacy pool — not a guarantee that the same clinician or pharmacy handles your specific order.

How the chain actually works

1. The storefront (SnagRx or Embody) takes your intake and your payment.
2. A clinician in the OpenLoop network reviews you and decides whether to prescribe. A prescription is not guaranteed.
3. A pharmacy compounds and ships it under a patient-specific prescription when legally permitted. The finished compounded drug is not an FDA-approved product.
4. A carrier delivers it. The pharmacy controls packing; the carrier controls transit.
5. You check the label, store it right, and take the dose your clinician set.

Notice how much of that the website doesn't control. That matters when something goes wrong and you're trying to figure out who to call.

The four pharmacies, both brands

Neither company tells you which one you'll get before you pay. Ask.

The exact question to ask before you pay

"Which pharmacy currently fills this program in my state, can that change mid-subscription, and does my price change if a different pharmacy is used?"

Both companies' terms allow prescriptions to move between pharmacies. So this is a fair question, and the answer is worth having in writing.

Check the label before your first dose

Confirm every one of these:

• Your name, and your prescriber's name
• The pharmacy that made it
• The medication and the strength in mg per mL
• Your dose in mg, and the exact syringe units that equal that dose
• The beyond-use date and storage instructions
• Supplies included — needles, syringes, alcohol swabs

If an injectable GLP-1 arrives warm or without enough refrigeration, do not use it. Photograph it, keep the packaging, and call the dispensing pharmacy for replacement or written instructions. That is the FDA's current advice.

About the dosing chart — one problem worth knowing

SnagRx publishes a dosing chart on its homepage. Embody's current main site doesn't. SnagRx's tirzepatide chart uses the expressions “10/mg” and “20/mg,” which are not usable dose units. Do not treat those numbers as weekly doses or use that chart to measure a vial.

We're reporting documents here, not making a medical claim about anyone's care.

SnagRx's homepage lists a “standard protocol for many patients”:

• Semaglutide: 0.25 mg a week for 4 weeks, then 0.5 mg a week for 8 weeks, bundled with an anti-nausea medicine. The page spells it “Ondanestron”; the drug is ondansetron.
• Tirzepatide: “10/mg for the first 4 weeks, 20/mg for the next 8 weeks.”

For comparison, the FDA-approved Zepbound label writes the weekly dose in mg: start at 2.5 mg once weekly for 4 weeks, move to 5 mg, then raise by 2.5 mg only after at least 4 weeks on the current dose. The maximum recommended weekly dose is 15 mg.

The same approved label also lists total vial or pen strengths such as 10 mg/2.4 mL and 20 mg/2.4 mL. Those are not the same thing as a 10 mg or 20 mg weekly dose.

So we are not going to claim SnagRx's chart proves a 20 mg weekly protocol. It doesn't say enough to prove that. The verified problem is that “10/mg” and “20/mg” do not tell a patient whether the number means dose, concentration, total vial strength, or something else. A dosing chart must separate dose in mg, concentration in mg/mL, volume in mL, and syringe units.

There's a second oddity. Both companies' results footnotes are based on patients “who reached and maintained a dose of 2.4 mg/week” of semaglutide — a dose SnagRx's own published 12-week chart never reaches.

What this means for you, practically: the prescription label and written instructions for the exact vial you receive are what count. Your clinician and dispensing pharmacy set them. A homepage chart does not.

One more safety note that applies to any compounded vial. The FDA has received reports of people taking 5 to 20 times their intended dose of compounded semaglutide, with some requiring hospitalization. The reason is simple and worth memorizing: dose (mg), concentration (mg/mL), volume (mL), and syringe units are four different numbers. Mixing them up is how overdoses happen. Use only the written instructions for the exact vial and syringe you were sent. Our safe online GLP-1 checklist shows what to verify before the first dose.

Are SnagRx and Embody legit? What the record shows.

Both have an identifiable legal operator, published terms, a named clinician network, and listed pharmacies. That is different from a site that hides the seller and pharmacy. But they share one Better Business Bureau file rated F, tied to 21 complaints with all 21 marked unanswered — and only Embody has a branded Trustpilot profile we could find.

Let's separate what's supported from what isn't.

Supported: these are identifiable businesses. They publish policies. They require a prescription. They name their clinician network and their pharmacies.

Not supported: that every order arrives on time, that every guarantee claim gets paid, that support always answers, or that the medication is FDA-approved. None of those follow from "it's a real company."

The shared BBB file

Two things to hold at once.

An F for not answering complaints is a genuine customer-service warning. Twenty-one out of twenty-one is a pattern, not bad luck.

But this company is not yet eight months old, BBB accreditation is voluntary, and BBB doesn't publish how many total customers there are — so nobody can turn 21 into a complaint rate. It doesn't prove fraud. It doesn't tell you what your order will be like.

Our read: it's real enough that you shouldn't prepay a big bundle on your first order.

The review gap between the two brands

This is the sharpest difference we found, and it's not about price.

Embody's Trustpilot profile: 3.8 out of 5 across 5,196 reviews at the time of our August 12 check. About 60% were five-star and 22% were one-star. Embody invites customers to leave reviews, and the profile has been merged with one or more other profiles — both of which shape the mix.

SnagRx: we searched Trustpilot and the wider public record but did not find a large, clearly attributable review profile under the SnagRx name. The shared BBB file does contain reviews. Meanwhile SnagRx's own homepage displays an "Excellent 4.8/5" badge and "125k+ Happy Customers," with no named review platform behind either number.

A 3.8 you can read beats a 4.8 you can't. That's the honest way to score this. Go read Embody's one-star reviews yourself — they're right there, and that's the point.

Three current service-review snippets

We picked these because they're attributable, they're about service rather than results, and together they show the actual spread.

“deliveries are on time” — P. Molina, verified reviewer, Trustpilot

“helpful and professional” — Amber, invited reviewer, Trustpilot

“No communication with company.” — Tom Cuneo, unprompted reviewer, Trustpilot

These are individual service experiences. They are not medical results, evidence about safety or effectiveness, or a promise of what will happen for you. Note the labels: Trustpilot marks whether a reviewer was invited by the company and whether a review is verified. That's worth reading before you weigh any of them.

About those LegitScript badges

Both sites display a LegitScript certification badge. LegitScript is a private company that reviews healthcare websites for compliance.

We did not perform a manual certification lookup for this audit. So we are calling the badges provider-stated for both brands rather than independently verified. If certification matters to your decision, check both domains in LegitScript's official verification tool before you pay.

Are SnagRx and Embody GLP-1 medications FDA-approved?

No. Both programs offer compounded semaglutide and compounded tirzepatide. Compounded drugs are not FDA-approved finished products and do not go through FDA review for safety, effectiveness, or quality before they're sold. The FDA's position is that a compounded drug should be used only when a patient's medical needs can't be met by an FDA-approved drug.

This is the single most important section on the page, so we're keeping it plain.

Compounded versus FDA-approved

What we will never write, and why

We don't call compounded semaglutide "generic Wegovy," "the same as Ozempic," "the same active ingredient," or "clinically proven." The FDA has warned sellers that those phrases can falsely imply an unapproved compounded product is the same as, interchangeable with, or proven like an FDA-approved drug. In March 2026, the agency announced warning letters to 30 telehealth companies over false or misleading compounded GLP-1 marketing.

Worth noting, since it goes to how carefully each brand writes: Embody's own FAQ says compounded GLP-1s "contain the same active ingredients found in brand-name medications" — while the footer of the same website says the medications are "not FDA-approved or evaluated for safety, efficacy, or quality." SnagRx's FAQ says "these are the same medications that people are talking about all over the country." We're reporting those claims. We're not repeating them as fact.

Is compounded semaglutide still legal in 2026?

Short answer: yes, in limited patient-specific cases. A state-licensed 503A pharmacy may compound for an identified patient under a valid prescription when federal and state requirements are met. It cannot simply mass-copy an approved drug because the copy is cheaper or easier to get. The rules have tightened a lot, and one separate 503B proposal is still moving.

Here's the timeline, dated:

• February 21, 2025 — FDA declared the semaglutide shortage resolved. Tirzepatide came off the shortage list in 2024.
• April 22, 2025 — FDA's semaglutide enforcement flexibility for state-licensed 503A pharmacies and physicians ended.
• May 22, 2025 — the same flexibility ended for 503B outsourcing facilities (larger operations that compound in batches).
• April 30, 2026 — FDA proposed leaving semaglutide, tirzepatide, and liraglutide off the 503B bulks list. If finalized as written, 503B outsourcing facilities could not rely on that list to compound these drugs from bulk substances when the approved drugs are not in shortage.
• May 1, 2026 — the proposal published in the Federal Register, opening a 60-day comment period.
• June 26, 2026 — comment period extended 30 days.
• July 30, 2026 — comment period closed.
• As of today, August 12, 2026 — FDA has not announced a final decision.

What this means for you specifically. The pending proposal is about 503B outsourcing facilities. Both brands market these programs as patient-specific 503A compounding, so the proposal does not by itself decide whether any one prescription from either brand is lawful.

The tighter rule already in force is different: a 503A pharmacy generally cannot make a drug that is essentially a copy of a commercially available approved drug unless the prescriber documents a change that produces a significant difference for that identified patient, or another legal basis applies. FDA's separate 503B analysis says supply backorders, convenience, and lower cost do not establish "clinical need" for the 503B bulks list.

That regulatory exposure is shared by both brands. If you'd rather not build a routine on top of rules that are still being enforced and refined, that's a completely reasonable place to land — and there's a door for that.

Decision point. If any of the last three paragraphs made your stomach drop, this is your exit and we'd rather you took it.

→ Compare FDA-approved GLP-1 options and check your insurance with Ro

Ro lists FDA-approved options including Zepbound® and Foundayo (orforglipron), offers a free insurance check for the Ozempic®, Wegovy®, and Zepbound® pens, and says its insurance concierge handles coverage paperwork for eligible options. Membership is $39 for the first month, then $149 month to month or as low as $74 a month with annual prepayment. Medication is billed separately.

Prescription required. Verify current pricing at checkout.

Which one ships faster and answers the phone?

SnagRx makes more specific speed claims than Embody, but neither company's terms guarantee a delivery date, and we have not run a controlled test. There isn't enough evidence to name a service winner.

Here's what each one advertises, labeled honestly.

One thing worth understanding: the storefront doesn't control shipping. The pharmacy controls processing time and cold-chain packing. The carrier controls transit. That's why review complaints about slow delivery are hard to pin on the brand — and why a fast delivery isn't proof the brand is great either.

Both terms say delivery estimates aren't guaranteed. Plan for some variability and don't let your supply run to zero.

Who should choose Embody, who should choose SnagRx, and who should walk

Embody fits a cash-pay adult who accepts compounded medication, is comfortable with the shared setup, and wants the lowest published price. SnagRx has no current price advantage at any plan length. Neither fits someone who needs an independent company, insurance help, or an FDA-approved medication.

Choose SnagRx only if you can name the reason

We're not telling you SnagRx is bad. We're telling you it costs more for the same published setup.

If you're going to pick it anyway, make sure the reason is real and written down: a confirmed pharmacy you prefer, a payment schedule that works better, a state availability difference, or something support puts in writing. "It was the first ad I saw" is not a reason worth $240.

Decision point. If the shared setup is fine with you and the price is the deciding factor, you already know the answer.

→ Check Embody's availability in your state and see today's plan terms

Confirm your state, your exact charge today, your commitment length, and your renewal date before you pay. A prescription isn't guaranteed.

Which states can use SnagRx or Embody?

Neither company gives a clean, complete answer. SnagRx's terms say all 50 states plus Washington D.C., while a notice on its own homepage says it can't serve Mississippi or Louisiana. Embody's terms only say "certain states" and tell you to email support; a separate public Embody landing page also excludes Mississippi and Louisiana but still does not publish a complete state list.

SnagRx contradicts its terms with its homepage alert. Embody gives a two-state exclusion on one landing page but no complete list in its terms or main site. Between the two, that's a wash — you have to check either way.

Your 60-second state check: enter your state in the intake before you pay, ask support to confirm availability in writing, ask whether your state requires a live video visit, and ask which pharmacy serves your state.

What to confirm before you pay

Save the exact price, the total commitment, your renewal date, the cancellation deadline, and the medication type from the checkout screen — not from the ad. When the ad and the checkout disagree, the checkout is what you agreed to.

Thirteen things. Screenshot all of them.

1. Does it say compounded?
2. The plan name and monthly rate
3. The exact amount charged today
4. The commitment length — 1, 3, 6, or 12 months
5. Whether it bills monthly or all at once
6. Your renewal date and renewal amount
7. Your cancel-by date (use at least 5 days, or a longer cutoff shown at checkout)
8. What happens to your money if a clinician declines you
9. Whether unused months are refundable (usually not)
10. Which pharmacy serves your state
11. The full written terms of any guarantee
12. A working phone number, portal, or email
13. Whether the final price can change because of the prescription or pharmacy — both terms reserve that right

Stop and don't pay if: the amount due today is bigger than expected, the commitment only appears after you enter your card, the checkout contradicts the ad, the compounded product is described as an approved generic, or support won't explain the renewal in writing.

How we researched this comparison

This is a document-based commercial comparison, not a treatment diary and not medical advice. We read both companies' live terms, refund pages, homepages, public product pages, and accessible landing pages on August 12, 2026; checked the BBB file directly; reviewed Trustpilot data; and used FDA materials for medical and regulatory claims. We did not enroll, pay, receive medication, or run a controlled support test with either company. Our editorial policy explains how we separate provider claims from verified facts.

What we verified on August 12, 2026

• snagrx.com homepage and Terms & Conditions (last updated July 27, 2026)
• joinem.co Terms & Conditions (last updated April 24, 2026) and Cancellation & Refund Policy
• Embody's current homepage, public product catalog, and an accessible promotional landing page
• The BBB business profile for Modern Metabolic Medicine, Inc.
• Embody's Trustpilot rating, 5,196-review count at our check, star distribution, invitation label, and merged-profile notice
• Searched for a SnagRx review profile — none found
• FDA compounding guidance and the 503B bulks list proposal timeline

What we could not verify — and we're telling you

• The exact checkout charge after any personalized or promotional adjustment. We read published terms and product pages, not a completed live cart.
• Whether Embody's multi-month plans bill monthly or all at once. Their terms don't say.
• LegitScript certification for either brand. We left it provider-stated and did not perform a manual lookup.
• Embody's complete current state list. Not published.
• The full written terms of either satisfaction guarantee.
• Which pharmacy fills any individual order.
• Support response times. We haven't run a controlled test.

One correction we owe you

Our July 15 Embody review cited a Trustpilot figure of roughly 2,200 reviews. At this August 12 check, Trustpilot showed 5,196. This comparison uses the newer number. When our numbers change, we say so and date it — that's our corrections policy.

Our labels: Verified (read at the source, dated) · Provider-stated (their claim, not confirmed) · Calculated (our math, shown) · Conflict (their own documents disagree) · Not disclosed (we looked; it isn't published).

Frequently asked questions

Are SnagRx and Embody the same company? Yes. Both are operated by Modern Metabolic Medicine, Inc., and the BBB lists SnagRx, RodeoMeds, and Embody as alternate names on a single business file.

Is Embody cheaper than SnagRx? Yes, on the monthly, 3-month, and 6-month plans. Semaglutide is $79 vs $99 monthly. The 12-month semaglutide rates tie at $69 per month, or $828 for the term.

Is Embody really $69 a month? No. Embody's terms list $79 as the month-to-month rate. The $69 rate applies to the 12-month plan.

Is SnagRx really $69 a month? No. SnagRx's terms list $99 month to month. The $69 rate is the 12-month plan, billed as $828 at once.

Is tirzepatide $119 a month at either one? Only on the 12-month plan. Month to month it's $129 at Embody and $149 at SnagRx.

Which is cheaper for a full year? Neither. Both come to $828 for semaglutide and $1,428 for tirzepatide on the 12-month plan.

Do they use the same doctors? Both name OpenLoop Health as their clinician network. That doesn't mean the same individual clinician reviews every patient.

Do they use the same pharmacy? They list the same four partners: RedRock, Health Warehouse, Precision Compounding, and Triad Rx. Neither names your assigned pharmacy before you pay.

Will the medication be identical? Don't assume it. The prescription, pharmacy, strength, and supplies can all vary. Your label tells you what you got.

Are these medications FDA-approved? No. Both offer compounded semaglutide and tirzepatide, which are not FDA-approved finished products and don't go through FDA review before sale.

Is it the same as Wegovy or Ozempic? No. Compounded semaglutide is not an FDA-approved generic and is not interchangeable with Wegovy or Ozempic.

Is compounded semaglutide legal right now? It can be compounded in limited patient-specific cases when federal and state rules are met. FDA proposed keeping semaglutide, tirzepatide, and liraglutide off the 503B bulks list on April 30, 2026; the comment period closed July 30, 2026, and we found no final determination as of August 12, 2026.

Am I charged before a doctor approves me? Yes, at both. Both disclose that a clinician meets you after checkout.

Do I get a full refund if I'm declined? Both refund pages promise a full medical-disqualification refund. Both terms say consultation fees are not refundable and only medication not yet dispensed may be refunded. The documents conflict, so get the exact dollar amount in writing before you submit the intake.

Is the cancel deadline 72 hours or 5 days? Both companies publish both numbers in different documents. Use 5 days.

Can I get a refund after the medication is ordered? Generally no. Once it's prescribed, compounded, or shipped, refunds are very limited.

What does Embody's 6-month guarantee cover? Embody advertises a 100% satisfaction refund if you follow the program and don't see meaningful progress in six months. The full terms aren't in its published policies. Ask support for them in writing.

What shows up on my bank statement? SnagRx charges appear as OPNLP-SNAGRX. Embody charges appear as Modern Metabolic Medicine, Inc.

Is SnagRx available in every state? No. Its homepage says it can't serve Mississippi or Louisiana, even though its terms say all 50 states plus D.C.

Is Embody available in every state? Embody does not publish a complete state list. Its terms say "certain states" and direct you to support; one public landing page says Mississippi and Louisiana are excluded.

Do they take insurance? These programs are presented as cash-pay, and both companies say their affiliated practices are out-of-network.

Can I use an HSA or FSA card? Embody advertises HSA/FSA acceptance. SnagRx's terms say it does not guarantee HSA/FSA eligibility. Check with your plan administrator and keep an itemized receipt.

Why does SnagRx have no Trustpilot page? We don't know. We searched and couldn't find one under the SnagRx name. That's a gap in the branded public record, not proof of anything — but it does mean the platform behind its "4.8/5" badge is not disclosed.

What does the BBB F rating mean? It's based on 21 complaints with 21 marked unanswered. It's a real customer-service warning. It doesn't prove fraud or predict your experience.

Should I switch from SnagRx to Embody? If you're paying $99 month to month and you're otherwise happy, Embody's $79 rate saves $240 over 12 months for the same published core setup. But it's the same company — switching won't fix a service problem.

Should I switch if I had a bad experience? Probably not to the sister brand. Same operator, same file, same core policies. Look at a provider offering FDA-approved medication or a different company entirely.

Is there something cheaper than both? Other providers may be cheaper for a specific dose, term, or medication, and prices change often. Our free matching quiz sorts by budget, state, and whether you want compounded or FDA-approved medication.

Do you get paid if I sign up? We may be paid if you start with Embody or another linked provider, including Ro. We earn nothing from SnagRx — they don't have a program with us. That is why the disclosure sits at the top, before our verdict, including the parts that may talk you out of buying.

The bottom line

Two websites. One company. Same named clinician network, same listed pharmacy pool, same core refund and subscription rules, same F-rated business file.

The biggest buying difference is what they charge. The bank descriptor, arbitration forum, and branded review trail differ too. Embody is $20 a month cheaper on the monthly plan, $39 cheaper across three months, $36 cheaper across six — and identical at twelve.

If compounded care is right for you, take the cheaper door and start monthly until they've earned more. If it isn't, go FDA-approved on purpose instead of by accident. Either way, you're deciding with the facts now instead of a countdown timer.

→ Check Embody's current pricing and eligibility

Prescription required. Compounded medication is not FDA-approved. Confirm your total and your cancel-by date before you pay.

Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.

→ Find my GLP-1 path

Sources

All commercial facts were checked on August 12, 2026.

• SnagRx — Terms & Conditions, last updated July 27, 2026
• SnagRx — homepage, pricing, FAQ, state alert, and dosing chart
• SnagRx — Refund Policy, last updated February 10, 2026
• Embody — Terms & Conditions, last updated April 24, 2026; active program updated July 1, 2026
• Embody — Cancellation & Refund Policy
• Embody — current homepage
• Embody — public product pages for the 3-month semaglutide supply, 6-month semaglutide supply, 12-month semaglutide supply, 3-month tirzepatide supply, 6-month tirzepatide supply, and 12-month tirzepatide supply
• Embody — accessible promotional landing page used for the shared-layout, logo-wall, dosing-chart, and two-state-alert comparison
• Better Business Bureau — Modern Metabolic Medicine, Inc. business profile
• Better Business Bureau — complaint summary
• Trustpilot — Embody reviews
• Reddit — discussion of the shared operator and SnagRx pricing thread; used only for attributed reader reactions
• U.S. Food and Drug Administration — FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
• U.S. Food and Drug Administration — Dosing errors associated with compounded injectable semaglutide
• U.S. Food and Drug Administration — Compounding and FDA: Questions and Answers
• U.S. Food and Drug Administration — Guidance on Essentially Copies Under Section 503A
• U.S. Food and Drug Administration — GLP-1 shortage and enforcement timeline
• U.S. Food and Drug Administration — FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide from the 503B Bulks List, April 30, 2026
• Federal Register — 503B proposal, May 1, 2026, 91 Fed. Reg. 23431
• Federal Register — 30-day comment-period extension, June 26, 2026
• U.S. Food and Drug Administration — 30 telehealth warning letters over compounded GLP-1 marketing, March 3, 2026
• U.S. Food and Drug Administration — Zepbound prescribing information
• U.S. Food and Drug Administration — Foundayo approval, April 1, 2026
• Ro — Weight Loss Program Pricing and free GLP-1 Insurance Coverage Checker

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. This page is general information, not medical or legal advice. A licensed clinician decides whether any treatment is appropriate for you.